Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
Though they are costly, broad genetic assays that look for many gene mutations at once may confer more value overall than a one-off testing approach for patients with nsNSCLC.
Whether a patient received NCCN guideline-concordant care seemed to depend most heavily on race and insurance status.
Clinical benefit scores of many anticancer medications approved during the study period seemed to improve at data follow-up.
The management of patients with cancer during a pandemic should be steered by evidence, as opposed to guidelines from individual institutions or consensus agreements between physicians.
The researchers noted that medical distancing for those with cancer could help prevent the spread of the virus in this highly vulnerable population.
Cannabis use is increasing among older adults — and the increase in use has been most prevalent among those who are not chronically ill.
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Even though older adults were prescribed second-line therapies less frequently than younger adults, patients had similar overall survival outcomes across age subgroups.